Cell Carrier, Methods of Making and Use
Global Life Sciences Solutions USA LLC
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 4 of these applications claim priority to application 12/970,735, filed Dec 16, 2010. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 9,534,206 | Cell Carrier, Associated Methods for Making Cell Carrier and Culturing Cells Using the Same In force · Medium confidence | Global Life Sciences Solutions USA LLC | In force | Medium confidence | ||
| US 9,518,249 | Cell Carrier, Associated Methods for Making Cell Carrier and Culturing Cells Using the Same In force · Low confidence | Global Life Sciences Solutions USA LLC | In force | Low confidence | ||
| US 9,453,197 | Methods of Making Cell Carrier In force · Medium confidence | Global Life Sciences Solutions USA LLC | In force | Medium confidence | ||
| US 9,453,196 | Cell Carrier, Methods of Making and Use In force · Medium confidence | Global Life Sciences Solutions USA LLC | In force | Medium confidence | ||
| US 9,957,478 | Cell Carrier, Associated Methods for Making Cell Carrier and Culturing Cells Using the Same Lapsed May 1, 2026 on the fee record Medium confidence | Global Life Sciences Solutions USA LLC | Lapsed May 1, 2026 on the fee record | Medium confidence |
5 of 5 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
4 of these are in force and held by Global Life Sciences Solutions USA LLC.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.